Genetix Group Announces Directorate Change
News Nov 30, 2005
The Board of Genetix Group plc has announced that Trevor Bell, Chief Operating Officer, will be resigning from the Board with effect from 11th January 2006.
Trevor is leaving the company as a consequence of changes planned for the composition of the Board which will result in the role of Chief Operating Officer becoming redundant.
With its new generation of products in the field of cell biology, the Board has identified a need to further strengthen its scientifically driven expertise at Board level.
Commenting on Trevor’s departure, John Morgan, Chairman said, "The Board would like to thank Trevor for the very significant contribution that he has made to Genetix."
"His professionalism and the impact that his wide-ranging business experience has brought to the company has been highly appreciated and he has participated actively in the decision to restructure the Board along the above lines. We wish Trevor every success in the future."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019